Tranexamic acid in brain contusion clinical trial

Phase 1

Recruiting

• Conditions: traumatic brain injury.; Focal traumatic brain injury

• Registration Number: IRCT20181225042112N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 February 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

non-surgical patients with moderate to severe head trauma (GCS: 3-12) with brain contusion

Exclusion Criteria

active bleeding in other sites
other causes that necessitates use of tranexamic acid
renal failure and creatinine more than 2

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Contusion evolution. Timepoint: every day in a week. Method of measurement: measuring the CT scan cuts.